Atlas Trials

High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer

Clinical trial NCT00547547 · COMPLETED

Trial details

NCT number
NCT00547547
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Unspecified Adult Solid Tumor, Protocol Specific
Start date
2006-04-01
Primary completion
2012-08-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.